Missing/wrong data?
Log in to edit
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...
scientific article (publication date: December 2015)
Author/s
author: Federico Piacentini, Eva M Ciruelos, Heikki Joensuu, Thomas Bachelot, Petri Bono, Pirkko-Liisa Kellokumpu-Lehtinen
Work details
Publication date
December 2015
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.